난민은 `행복한 환약' £30million를 위한 상사 추격한다

에 의하여 마틴 DELGADO

베스트셀러 약은 습관성 다는 것을 주장하는 환자를 대표해 변호사는 회사, £50,000까지의 각 찾는 보상에 대하여 600 고등 법원 영장의 첫번째 발행했다.

1990년에 브리튼에서 첫째로 시켜, Seroxat가 성인과 아이들의 적어도 50의 자살에 연결되었기 때문에.

GSK, which makes up to £1billion a year from the drug, is already embroiled in lawsuits with American users, and has been accused of failing to act on warnings that it could have serious side-effects, including mood swings and personality changes.

Expert advice on how to beat depression…

Mark Harvey, of law firm Hugh James, claims Seroxat is “defective” under the 1987 Consumer Protection Act.

He said: “When patients took the drug, not only was there no warning of withdrawal problems, there was also a statement on the data sheet until about 2003 which said you cannot be addicted to Seroxat.

“Unfortunately many people are havingdifficulties as they try to withdraw from the drug, and there are a few who have not been able to stop taking it.”

Earlier this year the BBC’s Panorama programme alleged that GSK had covered up fears about Seroxat’s safety, which the firm strongly denied.

The drug was banned for under-18s in 2003 amid concerns that it contributed to suicide among adolescents with depression, and adult patients have reported that, when they stop taking it, they feel aggressive, reckless and violent towards themselves.

Four years ago a man arrested for armed robbery was cleared after medical experts concluded that his behaviour could have been altered by severe withdrawal symptoms from Seroxat.

GlaxoSmithKline said: “Seroxat has benefited millions of people worldwide.

“We believe the product is not defective and that there is therefore no merit in this litigation.”

Comment on 'Sufferers sue ‘happy pill’ firm for £30million' :

RSS TrackBack URL

Related News: